March 6 (Reuters) - Argos Therapeutics Inc
* Argos Therapeutics Inc - On March 3, 2017, Argos Therapeutics, Inc entered into a payoff letter - SEC filing
* Argos Therapeutics - pursuant to payoff letter co agreed to pay off, thereby terminate venture loan and security agreement dated as of Sept 29, 2014
* Argos Therapeutics Inc - pursuant to payoff letter, company will pay, on or about March 6, 2017, a total of $23.1 million to lenders
* Argos Therapeutics - to issue to lenders 5-year warrants to purchase aggregate of 100,000 shares of co's common stock at exercise price of $1.30per share Source text: (bit.ly/2mWUP4s) Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.